高级检索

MicroRNA在心肌梗死临床诊疗中的应用进展

  • 摘要: 微小RNA(micro-ribonucleic acid, microRNA/miRNA)是一种小的非编码RNA,在调控基因的转录过程中起着重要作用。近年来研究发现,miRNA参与心肌细胞发育、增殖、凋亡等进程,可作为一种新型的生物标志物,在急性心肌梗死的早期诊断、预后甚至治疗等方面扮演重要角色。然而,目前miRNA在检测技术、机制研究及临床试验方面仍面临诸多问题和挑战。本文就上述系列内容作一综述。

     

    Abstract: MicroRNAs (micro-ribonucleic acid, miRNAs) are small non-coding RNA molecules, which play an important role in regulating gene transcription. Recent research has found that miRNAs can be used as a new biomarker because of being involved in the progresses of cardiomyocyte development, proliferation and apoptosis. They play an important role in the early diagnosis, prognosis and treatment of acute myocardial infarction. However, there are still many problems and challenges in detection technology, mechanism research and clinical trials of miRNAs.

     

/

返回文章
返回